In the latest period of Q4'25, CVS's Gross Margin stood at 12.8%, Operating Margin recovered to 2.0%, and Net Profit Margin improved to 2.8%, reflecting a rebound in profitability metrics after earlier challenges. Over the timeframe from Q1'23 to Q4'25, the chart reveals a predominantly declining trend across all margins, with Gross Margin dropping from 15.7% to 12.8% amid consistent erosion, Operating Margin fluctuating sharply from around 4.0% to a low of -3.1% in Q3'25 before partial recovery, and Net Profit Margin similarly weakening from 2.5% to a negative -3.9% in Q3'25, driven by significant dips in Q3'24 and Q3'25 that highlight operational pressures and volatility in the retail pharmacy sector. Key insights include the narrowing gap between Gross and Net Margins, indicating rising costs or one-time expenses impacting bottom-line efficiency, though the Q4'25 uptick suggests potential stabilization if cost controls persist.